qXR-LN is an FDA-cleared solution to assist physicians with early nodule detection. Studies have shown that AI is highly ...

The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received previous treatment, the drugmaker said on Wednesday.

The imaging agent called Cytalux works by having patients receive an infusion before surgery that causes cancerous cells to glow like neon highlighter under infrared light. Qatar pushes back on ...

SANTA MONICA, Calif. — A California man battling lung cancer is unable to get treatment he planned for after being denied by his health insurance company Cigna Healthcare. Daron Wells ...

A young Maryland woman is "relieved and recovering" after doctors performed a novel surgery to remove her potentially deadly cancerous tumors. A surgical team at the University of Maryland Medical ...

A team of researchers from Moffitt Cancer Center has found new insight into why some lung cancer patients do not benefit from tumor-infiltrating lymphocyte, or TIL therapy. Their findings, published ...

Impaired T cell and neoantigen retention in time-serial analysis of metastatic non-small cell lung cancer in patients unresponsive to TIL cell therapy. Nature Cancer , 2025; DOI: 10.1038/s43018 ...

Childhood brain tumors develop early in highly specialized nerve cells Date: May 7, 2025 Source: German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) Summary: Medulloblastomas ...

"However, the precise delineation of tumors for volume analysis—tumor contouring—poses practical challenges and often causes a bottleneck in research projects and clinical applications ...

The regimen has been evaluated in trials for a variety of solid tumors, including lung cancer, prostate cancer and pancreatic cancer. The FDA granted the regimen fast track designation for ...